BiotechTube
Home/Capacity Bio/Ken Horne
KH

Ken Horne

Chief Executive Officer

Capacity Bio

Therapeutic Areas

Mitochondrial DysfunctionAgingNeurodegenerative DiseasesMetabolic Diseases

Capacity Bio Pipeline

DrugIndicationPhase
Mitophagy AgonistUndisclosed (Mitochondrial Dysfunction)Pre-clinical

Leadership Team at Capacity Bio

AW
Amy Wang, PhD
Chief Operating Officer
AB
Aaron Bergener
Chief Financial Officer
KG
Kevin Gaffney, PhD
Chief Scientific Officer
KR
Kathleen Rodgers, PhD
Chief Medical Officer
OS
Orian Shirihai, MD, PhD
Scientific Advisor
View full Capacity Bio profile